| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Korro Bio, Inc. (KRRO) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 14 sells. KRRO is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| 10% | 1.54M | $21.38M | - | |
| 10% | 1.30M | $18.04M | - | |
| 10% | 1.30M | $18.04M | - | |
| 10% | 1.30M | $18.04M | - | |
| 10% | 1.30M | $18.04M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 2, 2020 | Lucchino David L.45 | President And CEO | Sell | 3,839 | $18.57 | $71,276.41 | -0.9% | |
| Jun 1, 2020 | Lucchino David L.45 | President And CEO | Sell | 11,875 | $17.91 | $212,653.94 | -2.7% | |
| May 21, 2020 | Marcus Joel S68 | Director | Sell | 5,000 | $18.81 | $94,052.50 | -1.5% | |
| May 20, 2020 | Loose Christopher R.62 | Chief Scientific Officer | Sell | 4,500 | $19.02 | $85,610.50 | -1.2% | |
| May 20, 2020 | Marcus Joel S68 | Director | Sell | 27,809 | $18.87 | $524,654.76 | -2.7% | |
| May 8, 2020 | Lucchino David L.45 | President And CEO | Sell | 10,478 | $18.18 | $190,494.23 | -2.4% | |
| May 6, 2020 | Loose Christopher R.62 | Chief Scientific Officer | Sell | 4,500 | $16.28 | $73,268.41 | -1.2% | |
| May 5, 2020 | Lucchino David L.45 | President And CEO | Sell | 5,239 | $16.19 | $84,834.60 | -1.2% | |
| May 1, 2020 | Lucchino David L.45 | President And CEO | Sell | 5,236 | $15.28 | $79,997.18 | -1.2% | |
| Apr 24, 2020 | Lucchino David L.45 | President And CEO | Sell | 729 | $16.35 | $11,919.44 | -0.2% |